News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sievers Eric
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 554 shares
@ $1.7, valued at
$941.8 |
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 555 shares
@ $3, valued at
$1.7k
|
|
| 06/01/2023 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 554 shares
@ $3.15, valued at
$1.7k
|
|
| 05/02/2023 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 555 shares
@ $3.37, valued at
$1.9k
|
|
| 04/03/2023 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 555 shares
@ $2.68, valued at
$1.5k
|
|
| 03/01/2023 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 554 shares
@ $2.98, valued at
$1.7k
Granted 240,000 options to buy
@ $3.95, valued at
$948k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 554 shares
@ $8.25, valued at
$4.6k
|
|
| 12/01/2022 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 555 shares
@ $11.01, valued at
$6.1k
|
|
| 10/04/2022 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 555 shares
@ $7.7, valued at
$4.3k
|
|
| 09/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 554 shares
@ $5, valued at
$2.8k
|
|
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 657 shares
@ $9.56, valued at
$6.3k
|
|
| 01/05/2022 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 795 shares
@ $19.63, valued at
$15.6k
|
|
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2021 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Sold 118 shares
@ $26.235, valued at
$3.1k
Sold 119 shares
@ $24.285, valued at
$2.9k
Sold 68 shares
@ $26.035, valued at
$1.8k
Sold 48 shares
@ $24.053, valued at
$1.2k
Sold 44 shares
@ $24.999, valued at
$1.1k
Sold 37 shares
@ $25.771, valued at
$953.5 |
|
| 10/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Sievers Eric (Chief Medical Officer) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 77,471 options to buy
@ $18, valued at
$1.4M
|
|
|
|